Fortrea Holdings Inc.

Stock Chart, Company Information, and Scan Results

$4.66(as of Jul 21, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Fortrea Holdings Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$4.66
Ticker SymbolFTRE
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,000
CountyUSA
Market Cap$424.6M

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc. In Our Stock Scanner

example chart graphic
Date: Jul 22, 2025Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Double BottomScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.